- Home
- IH vs SGMO Comparison
IH vs SGMO Comparison
Compare IH & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IH
- SGMO
- Stock Information
- Founded
- IH 1996
- SGMO 1995
- Country
- IH China
- SGMO United States
- Employees
- IH N/A
- SGMO N/A
- Industry
- IH Other Consumer Services
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IH Real Estate
- SGMO Health Care
- Exchange
- IH Nasdaq
- SGMO Nasdaq
- Market Cap
- IH 123.1M
- SGMO 122.8M
- IPO Year
- IH 2020
- SGMO 2000
- Fundamental
- Price
- IH $2.35
- SGMO $0.46
- Analyst Decision
- IH
- SGMO Buy
- Analyst Count
- IH 0
- SGMO 6
- Target Price
- IH N/A
- SGMO $4.50
- AVG Volume (30 Days)
- IH 8.4K
- SGMO 4.0M
- Earning Date
- IH 07-01-2025
- SGMO 08-05-2025
- Dividend Yield
- IH 3.54%
- SGMO N/A
- EPS Growth
- IH N/A
- SGMO N/A
- EPS
- IH 0.25
- SGMO N/A
- Revenue
- IH $126,344,481.00
- SGMO $63,756,000.00
- Revenue This Year
- IH $39.02
- SGMO N/A
- Revenue Next Year
- IH N/A
- SGMO N/A
- P/E Ratio
- IH $9.37
- SGMO N/A
- Revenue Growth
- IH N/A
- SGMO 239.92
- 52 Week Low
- IH $1.47
- SGMO $0.30
- 52 Week High
- IH $3.18
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- IH 55.32
- SGMO 38.27
- Support Level
- IH $2.20
- SGMO $0.49
- Resistance Level
- IH $2.39
- SGMO $0.51
- Average True Range (ATR)
- IH 0.10
- SGMO 0.04
- MACD
- IH -0.01
- SGMO 0.01
- Stochastic Oscillator
- IH 91.90
- SGMO 6.25
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.